Healthcare, health insurance and Medicare are hot topics and controversial topics at times too. Developments in this sector naturally impact our well-being and they also have a major effect on the economy and political circles.
To help you understand what is going on and what we expect to happen in the future, our highly-experienced Kiplinger Letter team will keep you abreast of the latest developments and forecasts (Get a free issue of The Kiplinger Letter or subscribe). You'll get all the latest news first by subscribing, but we will publish many (but not all) of the forecasts a few days afterward online. Here’s the latest...
Some early signs of how Medicare will handle drug price negotiations: Officials plan to announce the initial group of drugs later this year, the first 10 of 140 drugs for which the Centers for Medicare & Medicaid Services (opens in new tab) (CMS) will be able to negotiate the price by 2033.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
This will give manufacturers time to prepare for talks, which will start for Medicare Part D drugs in 2026 and 2027.
Among the factors that CMS will consider in valuing a drug:
- Clinical benefits
- The net price of alternatives
- Research costs
- Revenue
- Patent protections and
- Federal funding
The industry is warning about lower investment in certain kinds of drugs, namely small-molecule drugs, which are exempt from negotiations for seven years after approval by the Food and Drug Administration (opens in new tab) (FDA) vs. 11 years for large-molecule drugs or biologics. Small-molecule drugs are manufactured via chemical synthesis and include things like aspirin and other “medicine cabinet” pharmaceuticals.
This forecast first appeared in The Kiplinger Letter. Since 1925, the Letter has helped millions of business executives and investors profit by providing reliable forecasts on business and the economy, as well as what to expect from Washington. Subscribe or get a free issue of The Kiplinger Letter.
-
-
Consumers Won't Cut Mobile, Internet Spending, Despite Inflation: Kiplinger Economic Forecasts
Economic Forecasts Consumers Won't Cut Back on Mobile or Internet Spending, Despite Inflation: Kiplinger Economic Forecasts
-
Courts to Rule on Agency Powers: Kiplinger Economic Forecasts
Economic Forecasts The scope of agency power is under the spotlight in cases in the Supreme and Federal Courts: Kiplinger Economic Forecasts
-
Consumers Won't Cut Mobile, Internet Spending, Despite Inflation: Kiplinger Economic Forecasts
Economic Forecasts Consumers Won't Cut Back on Mobile or Internet Spending, Despite Inflation: Kiplinger Economic Forecasts
-
Courts to Rule on Agency Powers: Kiplinger Economic Forecasts
Economic Forecasts The scope of agency power is under the spotlight in cases in the Supreme and Federal Courts: Kiplinger Economic Forecasts
-
Deeper Regional Banking Crisis Unlikely after Triple Failure: Kiplinger Economic Forecasts
Economic Forecasts Deeper Regional Banking Crisis Unlikely after Triple Failure: Kiplinger Economic Forecasts
-
Spending Cuts Could Trigger Deeper Slowdown: Kiplinger Economic Forecasts
Economic Forecasts Spending Cuts Could Trigger Deeper Slowdown: Kiplinger Economic Forecasts
-
Travel Demand and Delays to Soar, So Plan Ahead: Kiplinger Economic Forecasts
Economic Forecasts Travel Demand and Delays to Soar, So Plan Ahead: Kiplinger Economic Forecasts
-
SpaceX in Good Shape Despite Test Flight: Kiplinger Economic Forecasts
Economic Forecasts SpaceX in good shape despite test flight concerns: Kiplinger Economic Forecasts.
-
TikTok Ban Winners and Social Media Changes: Kiplinger Economic Forecasts
Economic Forecasts TikTok Ban winners, LinkedIn changes: Kiplinger's analysis of the massive social media cross-platform shake-ups.
-
Debt Ceiling Will Be Averted but It Won’t Be Easy: Kiplinger Economic Forecasts
Economic Forecasts Debt Ceiling Will Be Averted but It Won’t Be Easy: Kiplinger Economic Forecasts
